As shown in Table 8, in patients with HBeAg-positive and HBeAg-negative chronic HBV infection (immune tolerant and inactive carrier phase), that is, in those HBV-infected patients with persistent normal ALT value, the presence of significant liver inflammation was higher in NAFLD group than that in the non-NAFLD group (68.750% vs. 43.571%, P = 0.011; 59.302% vs. 35.685%, P < 0.001; 61.864% vs. 38.583, P < 0.001 in chronic HBV infection with no evidence of CHB). Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.